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Splicing is regulated by complex interactions of numerous
RNA-binding proteins. The molecular mechanisms in-
volved remain elusive, in large part because of ignorance
regarding the numbers of proteins in regulatory com-
plexes. Polypyrimidine tract-binding protein (PTB),
which regulates tissue-speciﬁc splicing, represses exon 3
of a-tropomyosin through distant pyrimidine-rich tracts in
the ﬂanking introns. Current models for repression in-
volve either PTB-mediated looping or the propagation of
complexes between tracts. To test these models, we used
single-molecule approaches to count the number of bound
PTB molecules both by counting the number of bleaching
steps of GFP molecules linked to PTB within complexes
and by analysing their total emissions. Both approaches
showed that ﬁve or six PTB molecules assemble. Given the
domain structures, this suggests that the molecules occupy
primarily multiple overlapping potential sites in the poly-
pyrimidine tracts, excluding propagation models.
As an alternative to direct looping, we propose that repres-
sion involves a multistep process in which PTB binding
forms small local loops, creating a platform for recruit-
ment of other proteins that bring these loops into close
proximity.
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Introduction
The scale of alternative splicing is breathtaking. It has been
estimated on the basis of high-throughput sequencing of
mRNA that there are about 100000 signiﬁcant alternative
splicing events in humans, derived from about 90% of the
multiexon genes; this corresponds to an average of seven
events per multiexon gene (Pan et al, 2008; Wang et al, 2008).
The actual number of alternative isoforms of mRNA depends
on the combinations produced by each gene, but the number
could exceed a million. Despite such overwhelming numbers,
it seems that alternative splicing is not the result of errors
(Pan et al, 2008) and that the error rate of splicing is so low
that any errors may be in large part the result of misincor-
poration during transcription (Fox-Walsh and Hertel, 2009).
Many, possibly most, alternative splicing events are repre-
sented more abundantly in particular tissues (Castle et al,
2008; Wang et al, 2008). The introns ﬂanking tissue-speciﬁc
exons are enriched in a number of sequence motifs, the most
abundant of which contain UCUCU (Castle et al, 2008; Wang
et al, 2008). This is recognized as a site, or partial site, for
binding of polypyrimidine tract-binding protein (PTB) (Chan
and Black, 1995, 1997). PTB was characterized as a PTB
(Garcia-Blanco et al, 1989), and then identiﬁed as a possible
repressor of a muscle-speciﬁc exon (Mulligan et al, 1992).
Subsequently, it was shown to regulate the expression of a
number of mRNA isoforms, particularly some speciﬁc to
neural and muscle tissue (Grabowski and Black, 2001;
Black and Grabowski, 2003; Boutz et al, 2007; Spellman
et al, 2007; Venables et al, 2008). As the level of inclusion
of exons with nearby intronic UCUCU motifs is inversely
correlated among tissues with the abundance of PTB (Castle
et al, 2008), repression by PTB seems to be a widespread and
important contribution to tissue-speciﬁc gene expression.
Indeed, genome-wide analysis of PTB–RNA association sug-
gests that PTB is associated with transcripts from over 40% of
annotated human genes (Xue et al, 2009).
PTB has four RNA-binding domains of the RRM type, with
ﬂexible linkers after domains 1 and 2 (Petoukhov et al, 2006).
There are three isoforms of PTB, which differ in the length of
the linker between RRMs 2 and 3. PTB4 has the longest linker
and is the most effective repressor of Tpm1 exon 3 (Wollerton
et al, 2001). The individual RRMs bind RNA with low afﬁnity
and weak speciﬁcity for short pyrimidine tracts (Oberstrass
et al, 2005). Structural analyses of the individual RRMs and of
RRMs 3 and 4 together suggest that the ﬁrst three RRMs could
bind a consecutive sequence of at least 15 nucleotides but
that the fourth RRM would require linking sequences before
binding to a short pyrimidine tract (Oberstrass et al, 2005;
Lamichhane et al, 2010). In contrast, the occluded binding
site size on poly(U) for the intact protein was estimated to be
5nts (Perez et al, 1997). The protein was found by selection
experiments to recognize a pyrimidine-rich consensus of
26nts (Singh et al, 1995), although experiments with natural
substrates identiﬁed shorter high-afﬁnity motifs of UCUCUCU
(Chan and Black, 1997) or UCUU (Perez et al, 1997). In the
absence of other proteins, PTB binds to RNA with canonical
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2161motifs to form small complexes with nanomolar afﬁnity, and
then larger complexes non-cooperatively (Singh et al, 1995;
Amir-Ahmady et al, 2005; Clerte and Hall, 2006). The num-
bers of PTB molecules in the larger complexes were hard to
predict but seemed to correlate more with the overall length
of the pyrimidine tract than with speciﬁc motifs. An analysis
of genome-wide binding sites suggested that the level of
pyrimidines remains elevated over tens of nucleotides around
each site (Xue et al, 2009).
The mechanisms by which PTB association represses
splicing are unclear. In several cases, pyrimidine-rich tracts
are located on both sides of the regulated exon or splice site
(Wagner and Garcia-Blanco, 2001; Amir-Ahmady et al, 2005).
In the case of the neural exon of the Src gene, which is
repressed in most tissues by the binding of PTB, two separate
pyrimidine tracts on either side of the exon cooperate to form
an ATP-resistant complex containing unknown numbers of
proteins (Chou et al, 2000). The effect of this is to prevent the
interaction of U1 snRNPs, bound to the 50 splice site of the
exon, with components at the downstream 30 splice site
(Sharma et al, 2005, 2008), but the nature of the impediment
is unknown. Pyrimidine tracts are found on both sides of the
alternative exon 3 of a-tropomyosin (TPM1), but, compared
with the Src gene, they are longer and the pattern of regula-
tion is different. Exons 2 and 3 of TPM1 are mutually
exclusive (Figure 1). Exon 3 is used in most tissues because
it contains strong splicing signals (Mullen et al, 1991), and
the switch to exon 2 in smooth muscle cells is primarily the
result of repression of exon 3 through the pyrimidine-rich
tracts in the ﬂanking introns (Gooding et al, 1994; Perez et al,
1997). It is likely that the longer pyrimidine tracts (P3 and
DY) are bound by PTB in all cells (Singh et al, 1995; Perez
et al, 1997; Gooding et al, 1998), but that the strong splicing
signals override this except in smooth muscle cells. When the
branch site is weakened by mutations, exon 3 is strongly
repressed in HeLa cells (Gooding et al, 2006) by the P3 and
DY PTB-binding elements (CG and CWJS, unpublished data).
Although it is clear that PTB has a preference for binding to
pyrimidine tracts, the connection between PTB binding and
inhibition remains elusive. Two speculative models have
dominated thinking, both of which have been invoked also
to explain the activities of another repressor, hnRNPA1. One
suggestion is that repressor molecules bound to sequences
ﬂanking the regulated sites associate in a complex, forcing
the exon or site into a loop (Blanchette and Chabot, 1999;
Chou et al, 2000; Eperon et al, 2000; Wagner and Garcia-
Blanco, 2001; Nasim et al, 2002; Oberstrass et al, 2005;
Spellman and Smith, 2006). However, direct evidence for
this is lacking. Moreover, looping is not easily reconciled
with evidence that some other exons are regulated by single-
pyrimidine tracts (Shen et al, 2004; Izquierdo et al, 2005),
and an alternative model is that extended complexes propa-
gate along the RNA from the initial high-afﬁnity site(s)
(Eperon et al, 2000; Wagner and Garcia-Blanco, 2001; Zhu
et al, 2001; Spellman and Smith, 2006). Given that estimates
for the length of sequence bound or recognized by pure PTB
vary so widely and that there is a strong concentration-
dependent ability to form large complexes, it is impossible
to infer the nature of the repressor complexes from the
properties of the pure protein.
A critical factor in developing mechanistic models for any
regulated splicing reactions will be the ability to determine
the numbers of proteins bound to RNA in complexes formed
under splicing conditions. However, there are no methods
available for doing this, whether with puriﬁed complexes or
crude extracts, because of the complexity of the reactions:
pre-splicing complexes assemble in the presence of numerous
competing RNA-binding proteins, many of which have low
speciﬁcity and are likely to bind dynamically and sometimes
cooperatively. Such complexity may make it difﬁcult to
establish general principles for regulation, because different
sites may involve different conﬁgurations of bound proteins.
Despite considerable progress in identifying regulatory pro-
teins and their target sites, we are in the unhappy situation
that we do not know the molecular mechanisms operating at
even one site.
To address this critical limitation, we have developed single-
molecule methods for analysing the stoichiometry of protein–
RNA complexes formed in nuclear extracts. We show here that
ﬁve or six molecules of PTB assemble around exon 3 of rat
Tpm1 pre-mRNA, and we propose a model for the organiza-
tion of the complex. This is the ﬁrst report describing the
measurement of the stoichiometry of proteins in complexes in
nuclear extracts, and the method will be of widespread use in
investigations of many aspects of gene expression.
Figure 1 Sequences implicated in alternative splicing of exons 2
and 3 of TPM1.( A) Diagram of the alternative splicing patterns of
exons 2 and 3. The lower pattern is a default pattern, and the upper
is predominant in smooth muscle. Exons (boxes) and introns are
not to scale; numbers refer to lengths in nucleotides. Splicing of
exon 2 to exon 3 is prevented because the branch site (circle) in
intron 2 is too close to exon 2. (B) Diagram of the transcripts used in
this work. TM1 (562nts) contains all the elements around exon 3
demonstrated to be involved in the regulation of splicing: P3, 50nt
polypyrimidine tract providing binding sites for splicing factor
U2AF65 and regulatory protein PTB; URE, upstream regulatory
element of repeated UGC motifs; DUGC, repeated UGC motifs on
the 30 side of the exon; DY, polypyrimidine tract of 40nts, also
bound by PTB. TM2 contains mutations converting the three
putative high-afﬁnity UCUU motifs in P3 to UUUU, UUUU and
CCUU; TM3 contains two deletions totalling 12nts in the DY tract;
TM4 combines these mutations; TM1 trunc is truncated as shown.
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It has been shown previously that PTB binds to the pyrimi-
dine-rich tracts ﬂanking exon 3 and that these tracts are
essential for repression (Gooding et al, 1994, 1998; Perez
et al, 1997). To follow the binding of PTB to RNA among all
the other proteins in nuclear extracts, GFP-labelled PTB
(isoform 4) was expressed in HEK 293T cells and nuclear
extracts were prepared. RNA transcripts corresponding to
various portions of exon 3 and its ﬂanking intron sequences
(Figure 1) were transcribed from genomic fragments cloned
in plasmid pGEM4Z (Gooding et al, 1998; Gromak et al,
2003a) cut with EcoRI or AccI (TM1 Trunc) and annealed to
an oligoribonucleotide analogue complementary to the ﬁrst
nine nucleotides of the transcript that had been conjugated
with a ﬂuorescent label (Cy5) and biotin. Constructs TM2
and TM4 contain mutations in the three UCUU motifs in
element P3 (Gromak et al, 2003a), and constructs TM3 and
TM4 contained deletions of two short U-rich tracts in element
DY (Gooding et al, 1998). The transcripts were incubated in
the extracts under splicing conditions, and the complexes
formed were captured from diluted reaction mixtures on
streptavidin-treated silica slides. The signals from the GFP
and Cy5 ﬂuorophores were detected by total internal reﬂec-
tion ﬂuorescence (TIRF) microscopy (Conibear and Bagshaw,
2000), separated with a beam splitter and acquired on two
halves of an emCCD chip (Figure 2). Representative time
courses of GFP ﬂuorescence from single molecules of RNA
are shown in Figure 3. The survival times of the ﬂuorescence
from single molecules were no shorter than those from GFP
molecules deposited directly on the surface, indicating that
ﬂuorescence was terminated by bleaching rather than by
dissociation from the complex.
Quantiﬁcation of PTB molecules in each transcript
complex by single-step photobleaching
Novel strategies were needed to quantify the numbers of GFP-
PTB molecules associated with each transcript molecule.
Unlike analyses done with membrane proteins (Leake et al,
2006; Ulbrich and Isacoff, 2007) or small organic ﬂuoro-
phores (Shu et al, 2007), counting the number of steps in
which GFP molecules became progressively bleached was
impracticable because the variations in amplitude between
individual GFP molecules (see below) effectively masked the
individual steps in many cases (compare Figures 3B and C).
Selecting only those spots that produced clear steps would
leave open the possibility of accidental bias. However, it was
readily possible to distinguish complexes with only one GFP-
PTB, which behaved like the individual GFP molecules seen
in the absence of RNA (Figure 3A), from those containing
more than one, which could be identiﬁed by the duration of
the signal and the larger intensities (Figure 3C). This allowed
us to count the numbers of complexes with one GFP-PTB and
those with more than one. The total number of PTB mole-
cules in the complexes could be calculated by assuming that
(1) the total number of PTB molecules bound was constant
and (2) the proportions of PTB and GFP-PTB followed a
binomial distribution. The probability (p) that a molecule
Figure 2 Representative image showing co-localization of RNA
(red) and PTB protein (green). Nuclear extract containing GFP-
PTB was incubated with TM1 RNA previously annealed to Cy5-
labelled biotinylated oligonucleotide. The mixture was diluted and
injected into a chamber on a prepared silica slide. Fluorescence
from molecules attached to the surface was detected by TIRF.
Images obtained in the Cy5 and GFP channels have been super-
imposed. White circles show co-localized Cy5 and GFP signals.
Figure 3 Time recordings of GFP-PTB molecules. (A) Trace from
GFP-PTB in nuclear extract in the absence of added RNA, showing
the numbers of photons collected in frames of 300ms versus time of
observation. After about 23s, the molecule bleached in a single
step. (B) Trace from GFP-PTB co-localized with TM1 RNA. Five
possible discrete steps are marked by lines. (C)A si n( B), but in this
case, discrete steps cannot be assigned.
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unlabelled PTB, was determined by cross-linking of protein in
the extract to radioactive TM1 trunc RNA (Figure 4) and
found to be about 0.45.
The results from the analysis of about 1600 molecules
(Table Ia) show that the fraction of RNA molecules associated
with GFP-PTB bleaching in a single step rose from 18%, with
the longest wild-type transcript, to 68% with the shortest.
Table Ib shows the fraction of molecules expected to show
single-step bleaching with p¼0.45. The observed value of
18% for the wild-type transcript TM1 falls between the values
expected for 5 or 6 molecules of PTB. Similarly, the com-
plexes formed on TM2 and TM3 contain 4–5 molecules, those
on TM4 contain 3–4 and those on TM1 trunc contain 2.
The observation that removing the three high-afﬁnity UCUU
motifs from the P3 element (TM2) reduced the number of
bound PTB molecules by only one was surprising and sug-
gested that the common practice of predicting PTB-binding
sites by high-afﬁnity motifs is misleading.
Table II shows the fraction of labelled RNA molecules co-
localized with GFP-PTB (Table II), which reﬂects the afﬁnity
of the interactions. The fractions were reduced progressively
by mutations in either polypyrimidine tract (TM2 and TM3),
both tracts (TM4) and by truncation of the RNA immediately
downstream of P3 (TM1 trunc). These results provide an
independent conﬁrmation of the signiﬁcance of the single-
step photobleaching results in Table Ia.
Quantiﬁcation of PTB molecules in each transcript
complex by measurement of integrated intensities
Our second strategy involved counting the total number of
detected photons (TNPs) from GFP in each complex before
bleaching. For single GFP-PTB molecules, in the absence of
RNA, the probability density function for the TNP ﬁts a
normal probability density function (Figure 5B). On this
basis, a probability density function was calculated assuming
that the TNP would be Gaussian for each GFP-PTB within a
complex and that the number of complexes with i bound
GFP-PTB molecules (i¼1,2,3yb) would follow a binomial
distribution, as above. The observed TNP for all molecules in
each experiment was converted to a cumulative distribution
and ﬁtted by the corresponding cumulative distribution cal-
culated from the function described above (Figure 5). The
ﬁtting procedure was done with various values of p, the
probability that a PTB molecule bound to the RNA was GFP
labelled. The best global ﬁt was obtained with p close to 0.45
(Figure 5), suggesting that TM1 binds 5–6 molecules, TM2
and TM3 bind 4–5, TM4 binds 3–4 and TM1 trunc binds 1–2.
These results are in good agreement with the results from the
ﬁrst method (Tables I and II), although the ﬁrst strategy is
more sensitive to the numbers of molecules in smaller com-
plexes, and the second strategy is more sensitive to the
numbers of molecules in the larger complexes.
Together, our results show that ﬁve or six molecules of PTB
are bound to the wild-type a-tropomyosin RNA. Even though
these results were derived from non-muscle extracts, the
complexes are likely to represent the repressed state of
exon 3. Mutations that weaken the exon 3 branch site lead
to high levels of exon 3 repression in HeLa cells (Gooding
et al, 2006), which remains dependent on the P3 and DY PTB-
binding elements (CG and CWJS, manuscript in preparation).
As our transcripts do not contain the branch site, there would
be no interference with formation of a repressed complex.
Figure 4 Cross-linking of PTB and GFP-PTB in nuclear extracts.
SDS–PAGE analysis of proteins labelled with
32P by cross-linking to
radioactive RNA. The nuclear extract from 293T cells transfected
with plasmid expressing GFP-PTB was the same as that used
throughout this work. The other nuclear extracts were from un-
transfected HeLa and 293Tcells, as shown. The TPM1 substrate was
TM1 trunc; in lanes labelled C, the extracts were incubated with an
adenovirus pre-mRNA used as a substrate for splicing in vitro.
Table Ia Observed proportions of Cy5 (RNA) molecules in which
associated GFP-PTB is bleached in a single step
Substrate TM1 TM2 TM3 TM4 TM1 trunc
% Single step 18 (26%) 28 (36%) 29 (39%) 40 (47%) 68 (71%)
No. measured 472 288 319 342 159
The fraction of GFP spots that co-localized with Cy5 spots and
exhibited single step bleaching is shown for each substrate tested
(% single step). The values in parentheses show the highest value
for the fraction when ambiguous assignments are included (see
Materials and methods). The total number of measurements with
each RNA substrate is shown.
Table Ib Proportions of molecules showing single step bleaching
predicted with various values of n
Total number of PTB/RNA (b)6 5 4 3 2 1
p¼0.45 14 22 33 49 71 100
Theoretical values for the fraction of spots exhibiting a single
bleaching behaviour were calculated using a binomial distribution
for the complexes formed by b bound PTB molecules with the
fraction of PTB-GFP molecules equal to 0.45. The fraction of GFP
spots exhibiting single bleaching in extract in the absence of any
RNA substrate was 490%.
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TM1 TM2 TM3 TM4 TM1 trunc Oligonucleotide
No. Cy5 spots 334 657 866 1344 824 1724
% Associated with GFP-PTB 66 47 52 32 23 o5
No. measured 334 657 866 1344 824 1724
The fraction of Cy5 spots that co-localized with GFP spots relative to the total number Cy5 spots detected within imaging area is shown for each
substrate tested.
Figure 5 Cumulative distributions of total photon counts. (A) Observed cumulative distributions of the total photons collected for each RNA in
nuclear extract. Numbers were normalized to the total number of spots analysed for each transcript, shown in Table Ia. The abscissa is in
counts/pixel, that is, total counts over the 8 8 area per pixel. (B) The cumulative distribution for GFP-PTB in extract in the absence of added
RNA, with a curve ﬁtted assuming that each spot contained only one ﬂuorescent protein molecule. Inset, plot of residuals. Abscissa as in (A).
(C–G) Cumulative distributions for GFP-PTB bound to transcripts, with different ﬁts ﬁtted assuming that the total number of PTB molecules
bound was as shown in the individual legends.
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With the knowledge that only ﬁve or six molecules of PTB are
bound to TM1, and that the ﬁrst three RRM domains of each
PTB molecule contact in total only about 15 nucleotides
(Oberstrass et al, 2005), with additional binding by RRM4
elsewhere, our ﬁrst conclusion is that we can exclude models
in which PTB molecules occupy the RNA for 500 nucleotides
continuously between the upstream and downstream sites.
Instead, PTB must act directly through the discrete upstream
and downstream regions that it recognizes directly.
As the assignment of high-afﬁnity sites does not predict the
number of PTB molecules bound, nor their sites of binding,
we have combined the data in Table III with the sequence
speciﬁcities derived for each domain from the structures
(Oberstrass et al, 2005) to model PTB in the repressed
complex, assuming that in nuclear extract competition with
other proteins would tend to enforce binding only with
optimal sites. We allowed the inter-domain separation to
range from 1 to 6 nucleotides (based on an average inter-
domain distance of 4.5nm (Petoukhov et al, 2006). RRM4 has
a low-binding speciﬁcity (YCN) and, because of the back-to-
back packing of RRM3 and RRM4, it binds preferentially 15 or
more nucleotides away from RRMs 1–3 (Oberstrass et al,
2005; Lamichhane et al, 2010). As there would be a YC
sequence at a distance 415nts from any possible site for
RRMs 1–3, RRM4 binding does not provide a constraint and
was not taken into account. Analysis of the entire sequence of
TM1 showed that there were numerous overlapping candi-
date sites, almost entirely located within the known P3 and
DY-binding elements (Figure 6A). The maximum number of
proteins that could be accommodated simultaneously in P3
was three, although there are a number of possible arrange-
ments (Figure 6B). To test whether up to three proteins could
bind in practice, gel shift assays were done with TM1 trunc
RNA and various proportions of recombinant N-terminally
truncated PTB1 and full-length PTB4 proteins at a saturating
total PTB concentration of 4mM, in the absence of nuclear
extract. The results conﬁrm that this region could accommo-
date three PTB molecules (Figure 6C).
The correspondence between the binding we observed in
nuclear extract and the structure-based predictions was un-
derscored by the mutant TM2, in which mutations had
altered all three of the UCUU sequence motifs previously
believed to be the high-afﬁnity binding sites in P3 (Perez et al,
1997). These mutations reduce repression of exon 3 in
smooth muscle (Gromak et al, 2003b) and HeLa cells
(CG and CWJS, manuscript in preparation). Our results in
Tables I and III showed a reduction by one in the number of
PTB molecules bound in nuclear extract, and the number of
molecules predicted as described above to bind to P3 was
also reduced by one. In contrast, gel shift assays showed that
the mutations did not affect the binding of pure PTB to TM1
trunc (Figure 6D). This discrepancy in the gel shift assays is
explained by the use of the very high concentrations of pure
PTB and the high protein:RNA ratio used to measure stoi-
chiometry by gel shifts, under which conditions and in the
absence of competing or accessory nuclear proteins the
protein may bind to suboptimal sites.
If three molecules of PTB are bound to element P3 in TM1,
then only two or three could be bound to DY. The mutations
in TM3 cause loss of only one PTB from DY. Predictions based
on the domain structures, as above, suggest that up to two
molecules could bind DY simultaneously at optimal-binding
sites (Figure 6E), and that only one molecule would be able to
bind this region in TM3. Gel shift assays of DY with recom-
binant PTB appeared to show two bands with the N-termin-
ally truncated PTB1-N (Figure 6F), but up to three extra
bands appeared as PTB4 was added. Moreover, the back-
ground was more prominent, suggesting that the complexes
were less discrete or less stable than those on P3. One
interpretation of this is that each molecule of DY RNA was
bound by either two or three molecules of PTB. This might be
explained by a suboptimal arrangement accommodating
three molecules that is favoured when high concentrations
of pure protein are used, as noted above for the occupancy of
mutant P3 sequences. If this occurred to some extent in
nuclear extracts, then the presence of complexes containing
either two or three molecules of PTB in DY would account for
the observation that all transcripts except TM1 trunc (which
lacks DY) appear to be bound by either n or nþ1 molecules
of PTB.
We conclude that the use of single-molecule methods has
enabled us to measure the numbers of proteins in a splicing
repressor complex assembled in nuclear extracts on wild-type
and mutant sequences. These measurements have allowed us
to apply data from domain structures to identify probable
sites of binding of the proteins and to test the ability of the
model to accommodate the effects of the mutations.
Discussion
We have described here the ﬁrst use of single-molecule
methods to measure the number of molecules of a protein
in a complex assembled in nuclear extract. This is essential
information for any mechanistic models, but it has been
entirely lacking in all earlier research into the regulation of
pre-mRNA splicing and other steps in gene expression.
The difﬁculty arises partly from the nature of the proteins
involved and from the complexity of the reactions.
Bioinformatic and selection approaches to identify sequence
motifs that affect the selection or use of splice sites have
produced so many motifs (Coulter et al, 1997; Liu et al, 1998;
Schaal and Maniatis, 1999; Fairbrother et al, 2002; Wang et al,
2004, 2005, 2008; Zhang and Chasin, 2004; Han et al, 2005;
Zhang et al, 2005, 2008; Castle et al, 2008) that about three
quarters of all the nucleotides in an exon (Zhang et al, 2009)
or a quarter of all possible hexamer motifs (Wang and Burge,
2008) are likely to affect splicing. This is borne out by
experiments (Pagani et al, 2003; Singh et al, 2004). It is
presumed that most of these sequences are recognized by
proteins, but predicting which proteins bind where is not
straightforward. Numerous proteins bind pre-mRNA (Gabut
et al, 2008), but there are very few cases in which their
target sequences are well deﬁned. Even in cases where the
properties have been studied extensively, the binding sites
Table III Values of n, the number of PTB molecules per molecule of
RNA, inferred from the best ﬁts to cumulative distributions of total
photon counts
Substrate TM1 TM2 TM3 TM4 TM1 trunc
n 5–6 4–5 4–5 3–4 2
Results from Tables Ia and Ib and Figures 5C–G.
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The EMBO Journal VOL 29 | NO 13 | 2010 &2010 European Molecular Biology Organization 2166Figure 6 Ways of accommodating ﬁve PTB molecules on TM1 pre-mRNA. (A) Possible binding sites for PTB monomers (domains 1–3), based
on the sequence speciﬁcities inferred from the structures (Oberstrass et al, 2005). Each vertical line represents the ﬁrst nucleotide in the
potential binding site. The ordinate shows the number of potential binding sites that begin at the same nucleotide; such sites arise because of
the range of values allowed for the distance between the motifs recognized by each domain. The abscissa shows the position in the regulatory
region, with the P3 and DY elements and exon 3 delineated. (B) Possible arrangements for the binding of three molecules of PTB to the P3
element. Each horizontal line shows one possible arrangement. Coloured bars show the region bound by the three separate molecules in each
arrangement. Identical arrangements arise on different horizontal lines when RRM2 is predicted to bind at different positions within a
monomer but RRM domains 1 and 3 are at the same positions. The region marked ends at the last speciﬁc nucleotide recognized by domain 3
and does not include the two additional nucleotides bound by the domain (Oberstrass et al, 2005). (C) Gel shift analysis of PTB binding
capacity of TM1 trunc RNA. The left-hand lane contained RNA only. The other lanes contained, from the left, RNA incubated with His-tagged
PTB4 at 4, 3.5, 3, 2.5, 2, 1.5, 1, 0.5 and 0mM, and sufﬁcient His-tagged PTB1-N (containing a deletion of the N-terminal 54 amino acids) to
maintain a total PTB concentration of 4mM. Electrophoresis was done on a 4% polyacrylamide gel. Labels to the right of the image show our
interpretation of the compositions of the bands. (D) Gel shift analysis of PTB binding capacity of mutant TM1 trunc RNA. The substrate is
derived from TM2 and contains the mutations in the P3 element that change the three putative high-afﬁnity UCUU motifs in P3 to UUUU,
UUUU and CCUU and strongly reduce repression. The protein concentrations and conditions of electrophoresis are as in Figure 6C. (E) Possible
arrangements for the binding of two PTB molecules to the DYelement, labelled as in (B), in which both molecules are located at optimal sites.
(F) Gel shift analysis of PTB binding capacity of RNA from the DYelement. The transcript contains nucleotides 449–562, that is, all of the DY
element shown in Figure 6E. The protein concentrations and conditions of electrophoresis are as in Figure 6C. Possible assignments are shown.
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on whether they are assayed with pure protein (Tacke and
Manley, 1995), functional selection (Liu et al, 1998; Smith
et al, 2006) or cross-linking in cells (Sanford et al, 2008) and
in all cases they are diverse. It is likely, therefore, that the
composition of pre-mRNP is the result of competition among
proteins with overlapping binding preferences, each with a
range of afﬁnities for different sequences (Abdul-Manan and
Williams, 1996) and sometimes able to bind cooperatively.
Prediction is therefore difﬁcult, experimental validation in
bulk assays requires puriﬁcation with all the artefacts that
entails, and puriﬁed proteins will have opportunities that
would be denied to them in the nucleus. However, the
problem of pre-mRNP composition can be addressed by
single-molecule methods.
We expected to be able to count the number of ﬂuorescent
proteins attached to the pre-mRNA by following bleaching
steps (Figure 3). However, this proved impracticable and
subjective for a high proportion of molecules due to the
differences in amplitudes of emission from individual mole-
cules. The presence of a signiﬁcant fraction of unlabelled
PTB in the extract was an advantage, because it allowed a
large fraction of the complexes to form with only one GFP-
PTB molecule, which can be identiﬁed readily. We assumed
that the proportions of complexes containing various num-
bers of labelled and unlabelled PTB followed a binomial
distribution. This approach was supported by the discovery
that the proportions of complexes containing a single GFP-
PTB increased as expected with increasing numbers of muta-
tions in the substrates that compromised PTB binding
(Table I). Moreover, there was an inverse relationship bet-
ween this proportion and the proportion of RNA molecules
associated with GFP-PTB, as predicted. In addition, we
measured the TNPs from co-localized GFP-PTB/RNA spots
until they bleached, which produced a modiﬁed Gaussian
distribution (see Materials and methods). This produced
results that were almost entirely consistent with the ﬁrst
method (Table III).
These approaches allowed the number of bound proteins
to be determined, within errors due to uncertainties intrinsic
to the splicing complex and TIRF microscopy. For instance,
we modelled the distributions of complexes assuming that
each molecule of each transcript type contained the same
number of PTB molecules. This is partly supported by gel
shift assays of TM1 in nuclear extract, which produce a
single, well-deﬁned band (Supplementary Figure S1), and
by single-molecule studies with recombinant PTB that show
that TM1 has 5–6 binding sites for PTB (Y Kafasla and DC,
data not shown). Another source of uncertainty arose from
the large variations of emission amplitudes. These may be the
result of restricted movement of tethered complexes ran-
domly oriented on the imaging surface, strong polarization
of the evanescent ﬁeld and the collection efﬁciency function
of the objective. The close proximity of bound PTB molecules
to each other (distances o10nm) does not exclude
homoFRET occurring between GFP molecules. The latter
can modulate (in a non-linear manner) the overall intensities
of GFP molecules and their life times (Luchowski et al, 2008).
The fraction of complexes with single GFP-PTB molecules
might be reduced by the slight tendency of eGFP to dimerize,
although our results in the absence of RNA suggest that this
affects o10% of the complexes. Nevertheless, we believe that
these uncertainties are relatively small and our simple models
give good approximations of the experimental data.
Knowing that TM1 contains ﬁve or six molecules of PTB, it
became feasible to predict the binding sites on the substrate.
Potential sites were mapped by combining the binding pre-
ferences of individual domains (Oberstrass et al, 2005) with
estimates for the lengths of ﬂexible linkers between them
(Petoukhov et al, 2006). Interestingly, this approach revealed
a multiplicity of arrangements that satisﬁed the conditions,
but it was possible at most to ﬁt only three optimally bound
molecules on P3 and two on DY. The multiplicity of possible
sites for the protein in P3 and DY and the multiplicity of
arrangements possible for three domains within each site
could contribute to a much higher apparent afﬁnity for the
ﬁrst PTB molecule to bind. The lack of experimental evidence
for binding to other candidate sequences in TM1 (at B340
and 410 nucleotides in Figure 6A) might be the result of
weaker apparent binding, because the level of multiplicity is
much reduced, as well as competition with other proteins.
The ﬁrst PTB molecule bound to P3 or DY might interfere
with subsequent binding by additional molecules. However,
PTB comprises ﬂexibly linked domains that each recognize
only two speciﬁc nucleotides (Oberstrass et al, 2005), and we
suggest that this arrangement might permit relatively facile
shufﬂing on pyrimidine tracts, thereby reducing the interfer-
ence with binding of second and third molecules.
Our results provide important insights into the nature of
the repressor complex. Figure 7A represents models in which
repressor complexes use cooperative interactions to propa-
gate along the RNA away from high-afﬁnity sites (Wagner
and Garcia-Blanco, 2001; Spellman and Smith, 2006). PTB
Figure 7 Models for the repression of exon 3 by PTB and associated
proteins. (A) Propagation of extended complexes from high-afﬁnity
sites (Wagner and Garcia-Blanco, 2001; Spellman and Smith, 2006).
The P3 and DYelements are shown as blue lines. Molecules of PTB
are represented by ovals. (B) Looping formation between the P3 and
DY elements, each bound by RRM domains 3 or 4 (Wagner and
Garcia-Blanco, 2001; Oberstrass et al, 2005; Spellman and Smith,
2006). PTB is shown in black; each RRM domain is represented by
an oval, RRMs 1, 2 and 3 connected by linkers and in contact with
the RNA, and RRM4 in close contact with RRM3 through their a-
helical surfaces. (C) Model based on our results. Left, ﬁve or six
molecules of PTB are associated with the transcript; three are
associated through domains 1–3 with P3 and two or three similarly
with DY. RRM4 of each PTB molecule is proposed to contact a
relatively close C-rich tract. Right, raver1 could interact with
RRM2 of each PTB monomer, thereby stabilizing either the PTB
assembly on each element or, as suggested by the arrow, between
the elements. MBNL1 multimers might further contribute to repres-
sion by binding the UGC motifs in the loops formed by the PTB
complex.
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Raver1 contributes to repression of exon 3 (Gromak et al,
2003a) and could fulﬁl this function. It has four
potential PTB-binding motifs that interact with the a-helical
face of RRM2 (Rideau et al, 2006), and it was possible that it
could facilitate the formation of extended complexes.
However, the length of RNA bound by a single molecule of
PTB is quite insufﬁcient for ﬁve molecules to span over
500 nucleotides, and we consider that this model can be
rejected for PTB.
As both P3 and DY are essential for repression through
binding of PTB, models have been suggested in which there
are looping interactions between proteins bound to the two
regions. Loops might repress splicing, as seen in the effects of
secondary structures around exons in vitro (Solnick, 1985).
RRM domains 3 and 4 of PTB associate back-to-back and bind
the RNA in opposite orientations, with a preference for at
least 15 nucleotides between them (Oberstrass et al, 2005;
Lamichhane et al, 2010). A natural suggestion is therefore
that the 450nts between P3 and DYare placed in such a loop
(Oberstrass et al, 2005; Spellman and Smith, 2006). It is
difﬁcult to predict the likelihood of collision between PTB
attached to one strand with a second RNA sequence, because
the binding of proteins to the sequences within the potential
exon-containing loop will affect the ﬂexibility of the RNA.
However, we note that other interactions that might involve
looping are restricted to a range of o300nts (Lavigueur et al,
1993; Graveley et al, 1998), and it would be expected that
shorter loops would be more likely to form.
As the only known requirements for loop formation by
RRM4 are that the distance from RRM3 is 15nts or more and
the domain binds YC (Oberstrass et al, 2005; Lamichhane
et al, 2010), it is not possible to predict with any conﬁdence
where RRM4 might bind. RRM4 is known to be essential for
the repression of splicing but to make little or no contribution
to the afﬁnity of PTB (Liu et al, 2002). If the probability of
binding by RRM4 is increased by proximity (beyond 15nts) to
RRM3 and by an abundance of cytosines, then it is possible
that it binds heterogeneously to any of a number of C-rich
tracts downstream of P3 and upstream of DY, forming small
loops as shown in Figure 7C. Raver1 may interact with PTB
proteins on each side of the exon or it may bridge the now-
smaller distance across the exon. The small loops would
contain the UGC-rich URE and DUGC elements.
Muscleblind-like protein (MBNL) is known to bind these
sequences and we have evidence that it contributes to
repression of exon 3 (CG and CWJS, manuscript in prepara-
tion). MBNL binds structured regions (Warf and Berglund,
2007; Yuan et al, 2007), and it may be that one function of
PTB is to facilitate re-structuring of the RNA. MBNL can self-
associate and even form large rings (Yuan et al, 2007), and it
would be a good candidate for stabilizing a loop that seques-
tered the 30 and 50 splice sites of the exon (Figure 7D). What
we suggest, therefore, is that assembly proceeds in at least
two stages, and that PTB association provides a platform for
subsequent recruitment of Raver1 and/or MBNL or other
regulatory proteins. It is now an important and practical
objective to determine the numbers of molecules of Raver1
and MBNL in these complexes. We believe that the single-
molecule approaches described here will prove to be of
widespread use in revealing the stoichiometry of many
other complexes involved in gene expression.
Materials and methods
Plasmids, oligonucleotides and extracts
The plasmids used for transcription and the mutant versions
of Tpm1 were as described (Gooding et al, 1998; Gromak et al,2 0 0 3 a ) .
For transcription, plasmids were digested with either EcoRI (full-
length RNAs) or AccI (TM1 trunc) and puriﬁed by phenol/
chloroform extraction. Transcription was done with T7 RNA
polymerase (Epicentre) in 40mM Tris–HCl, pH 7.9, 20mM MgCl2,
10mM NaCl, 2mM spermidine, 10mM DTTand NTPs each at 4mM,
with incubation at 371C for 4–5h. Transcripts were puriﬁed by
treatment with DNase1, phenol/chloroform extraction, separation
on an S-300 MicroSpin column (GE Healthcare; for the full-length
transcripts) and ethanol precipitation. The quality of the transcripts
was checked by gel electrophoresis.
For tethering RNA to the surface, oligonucleotide Cy5-50-
TUGUCUCCCAU-30-biotin was used (Eurogentec, Belgium) where
the underlined bases are LNA analogues and the others are 20-OMe
analogues. The oligonucleotide was complementary to the ﬁrst nine
nucleotides of either pre-mRNA. It had been puriﬁed by gel
electrophoresis, electroeluted, desalted and lyophilized.
Annealing was done with RNA and oligonucleotide both at 1mM
in 10mM Hepes, pH 8.0, 100mM NaCl by heating the mixture to
801C for 5min, cooling over 1.5h to 501C, and placing on ice for
1.5–2h. The presence of any residual unannealed oligonucleotide
(o10%) was checked by gel electrophoresis followed by imaging of
Cy5 ﬂuorescence on a PhosphorImager 9400 (Typhoon, GE
Healthcare). Note that its presence has little effect on the data as
o5% of the molecules co-localize with GFP-PTB (see Table II).
Nuclear extracts were prepared from transfected HEK293T cells
as described (Lee et al, 1988). Western blots showed that the GFP-
PTB comprised about 70% of the total PTB in the cells (data not
shown). Cross-linking was done in nuclear extracts as described
(Eperon et al, 2000), using RNA transcribed with [a-
32P]UTP. For
gel shift assays, transcripts were incubated with puriﬁed recombi-
nant protein (Wollerton et al, 2001) and analysed as before
(Gooding et al, 1998). Gel shift assays of TM1 RNA incubated in
nuclear extract showed no evidence of gross heterogeneity in
complex formation (Supplementary Figure S1).
Preparation of samples
Splicing complexes were assembled by incubating the annealed
RNA at 50nM under standard splicing conditions and then diluted
with buffer A (10mM Hepes, pH 7.5, 50mM NaCl) to a ﬁnal RNA
concentration of about 3pM. Samples were analysed using a ﬂow
chamber, as described (Conibear and Bagshaw, 2000). First,
biotinylated BSA (Sigma) was diluted in a buffer A to 10mg/ml
and injected into the chamber, followed by rinsing in the same
buffer A, injection of streptavidin (Pierce) diluted to 10mg/ml,
rinsing again, and ﬂushing with the same buffer containing RNasin.
25ml of diluted incubation mixture was then injected into ﬂow
chamber. When a sufﬁcient number of ﬂuorescent spots appeared
on both halves of the emCCD chip, the chamber was ﬂushed again
with the same buffer.
Acquisition of data
Single molecules were detected by a custom-built prism-based total
internal reﬂectance ﬂuorescence microscope (Conibear and Bag-
shaw, 2000). Excitation was done with an argon ion laser at 488nm,
with an incident power at the prism of B100W/cm
2, and a HeNe
laser at 633nm with an incident power of B50W/cm
2.
Fluorescence emission was collected by a 63x 1.2 N.A. Zeiss
C-apochromat water immersion lens, split by a dichroic mirror
(540DCLP, Omega) and projected onto two halves of the detector
chip (iXon DV887 emCCD camera, Andor Technology, UK) through
emission ﬁlters speciﬁc for eGFP and Cy5 chromophores (510DF23
and 670DF40, Omega, respectively) using a home-built beam
splitter. The acquisition rate was 300ms per time bin. Cy5
ﬂuorescence was acquired until the molecules were bleached
(about 15–30 frames) and then imaging was continued with
488nm laser excitation for 300–400 frames. The camera conversion
factor (counts/photon) was determined as described (Cherny et al,
2009). The spatial resolution of the microscope was B130nm/pixel
in the imaging plane.
For each time series, an accumulated image was calculated to
identify co-localized spots. Usually 423% of Cy5 signals were co-
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the fraction of co-localized Cy5 spots was o5%. Time series
intensities were analysed for co-localized spots using an area of
8 8 pixels, as the average apparent width (FWHM of a Gaussian
ﬁt) of the spots was 2.6–2.8 pixels. Spots that deviated signiﬁcantly
from a Gaussian ﬁt were not counted (o5%).
Analysis of bleaching steps
More than 90% of the signals from individual GFP-PTB molecules
in the absence of exogenous RNA showed a single-bleaching step.
The duration of emission varied signiﬁcantly in the range 2–30s
with the mean of about 10s. Emissions from GFP-PTB associated
with Cy5-labelled RNA showed a noticeably longer duration, with a
dramatic increase in the number of apparent bleaching steps but a
reduction in their resolution. Emissions from a fraction of these
GFP-PTB molecules exhibited single-bleaching behaviour similar to
that observed in the absence of RNA. Assuming that the number of
bound PTB molecules, b, is constant but speciﬁc for each RNA
tested and taking into account that complexes formed with
unlabelled PTB only are not detectable, the fraction of complexes
with only one bound GFP-PTB molecule, Pb,exp
1 , can be calculated
using a binomial distribution,
P1
b;exp ¼
bpð1   pÞ
b 1
P b
1
i
b
  
pið1   pÞ
b i
¼
bpð1   pÞ
b 1
1  ð 1   pÞ
b ;
where p is the probability that bound PTB is GFP labelled (p is close
to 0.5). Calculating the fraction of the complexes exhibiting a
singular bleaching behaviour allows b to be estimated for each type
of complex.
There are possibly several uncertainties in b. One of them is
partial GFP bleaching at the beginning of the experiment (o10%).
From the above formula it follows that DP1
b;exp ¼ qDP1
b;expDp=qp and
therefore |DPb,exp
1 | is in the range 0.04–0.06 when P is close to 0.5
and b¼2–6. The latter can be translated into an error of b using
DP1
b;exp ¼ qDP1
b;exp Db=qb. This means b can be underestimated due
to partial GFP bleaching by B0.6 for b¼5, B0.45 for b¼4, B0.3
for b¼3 and B0.15 for b¼2. Another source of errors is the large
variation of intensities and/or duration of the emission for
individual GFP molecules (see below), obscuring the detection of
complexes exhibiting a single-step bleaching. These uncertainties
(given in Table Ia) lead to similar errors in the estimation of b as
above but with the opposite sign.
Analysis of the TNPs
The majority of the signals (490%) from individual GFP-PTB
molecules in the absence of exogenous RNA showed a single-
bleaching step behaviour characteristic to single molecules, albeit
with a wide range of amplitudes from 50 to 250 photons per time
bin with large variance. Emissions from GFP-PTB associated with
Cy5-labelled RNA showed a much larger amplitude and variance
indicative of several GFP-PTB molecules within each complex. To
calculate the TNPs, the intensities for each time trace were
corrected for the background signal. The latter was calculated as
the mean from the same area after total bleaching of GFP. If there
was no apparent bleaching before the end of the acquisition,
juxtaposed 8 8 areas were used for background calculation. In the
absence of RNA, the distribution of TNP has a Gaussian-like shape
spanning the region from B200 to 10000 photons, with a maximum
around B1200 photons (Supplementary Figure S2), whereas in the
presence of TM1 substrate RNA, the distribution is much broader
with an apparent maximum around B3500 photons. To gain insight
into this distribution, we applied the Kolmogorov–Smirnov (KS)
statistic, which is superior for small sample sizes (Lilliefors, 1967).
We note that the small fraction of the molecules (o10%) that did
not exhibit single-bleach behaviour was excluded from the analysis.
Brieﬂy, we took the range of intensities from 0 to 10000 photons,
divided it into with 2000 steps and binned the data accordingly.
Normalization by N, the number of measured GFP spots, yielded a
discrete density function, e(i), i¼1, m (m¼2000 in our case). Such
a distribution density is related to a Gaussian p.d.f. of the variable I,
with m and variance, s
2:
gðI; m; sÞ¼
1
s
ﬃﬃﬃﬃﬃﬃ
2p
p exp  
ðI   mÞ
2
2s2
  
The cumulative distribution of the experimental data, EðiÞ¼ Pi
j¼1 eðjÞ, was ﬁt by the cumulative distribution of the function
g(I, m, s):
PrðIapp4ZÞ¼
Z z
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The best ﬁt, varying m and s, was obtained by minimizing the KS
statistic:
D ¼
ﬃﬃﬃﬃ
N
p
max½jðPrðiÞÞ   EðiÞj 
The D value was found (using Mathematica 5 and Global
Optimization module) to be B0.70, which is below the 0.20
signiﬁcance level (D0.20¼0.736; Lilliefors, 1967), implying that the
experimental distribution of TNP can be adhered to a normal
probability density function. The distribution of TNP did not
depend on the intensity of the 488nm laser in the range from 20 to
50mW. We note that our aim was to deﬁne a model describing the
distribution of TNP rather than absolute values for the mean and
variance.
Cumulative distributions were built similarly for the data from
each experiment with TM RNA. Using the above assumptions, that is
(1) the number of bound PTB molecules, b,i sc o n s t a n t( b41) but
speciﬁc for each RNA, (2) the fraction of complexes with 0, 1, 2y,b
PTB-GFP molecules follows a binomial law, (3) the complexes lacking
PTB-GFP molecules are not detectable and (4) PTB and GFP-PTB
exhibit similar afﬁnity for the speciﬁc sites, the corrected fraction for
the complexes with i (i¼1, 2,yb) PTB-GFP molecules is equal to
P1
b;exp ¼
i
b
  
pið1   pÞ
b i
P b
1
i
b
  
pið1   PÞ
b i
¼
i
b
  
pið1   pÞ
b i
1  ð 1   pÞ
b
Assuming that each GFP-PTB molecule in a complex would behave
likewise, the p.d.f. for the complexes with i bound PTB-GFP
molecules will be:
GFPðI; m; s; iÞ¼gðI; im; s;
ﬃﬃ
i
p
Þ¼
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The p.d.f. for the population of complexes containing b bound PTB
molecules would be:
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The cumulative distribution of GFP(I, m, s, b)w o u l db e :
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Individual ﬁts for each RNA substrate were optimized ﬁrst by varying
m, s and b with p around 0.45 to estimate b. It became clear that b
corresponds to 5–6 for TM1, 4–5 for TM2 and TM3, 3–4 for TM4 and
B2 for truncated TM1 RNA. The combination 5, 4, 4, 3 and 2 for
TM1, TM2, TM3, TM4 and TM1 trunc RNA, respectively, is ﬁtted
better by slightly higher values of p (e.g. 0.47, as shown in Figures
5 C – G ) ,w h e r e a st h ec o m b i n a t i o n6 ,5 ,5 ,4a n d2i sﬁ t t e db e t t e rb y
slightly lower values, such as 0.42. As every experimental cumulative
distribution exhibits small deviations from the expected distribution,
seen as a deﬁciency at the smaller numbers of TNP and over-
population for the middle values, the expected distributions with the
values of b that ﬁt most closely for each substrate with the same
values for m, s and p are shown in Figure 5C–G). We note that the
assumption about homogeneity of the complexes, that is b is constant
for each substrate, is not very stringent. Simple calculations show that
heterogeneity of the complexes, that is the presence of complexes
containing  1o rþ1 bound PTB molecules of up to 20–30%, will
effectively lead to the cumulative distributions within the indicated
boundaries. The TNP distribution can also be analysed by a novel
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maximum (DC, unpublished results). This gives similar results.
Prediction of sites and arrangements of binding
The binding preferences for RRM domains 1–4 of PTB were inferred
from NMR structures to be YCU, CU(N)N, YCUNN and YCN,
respectively (Oberstrass et al, 2005). On the basis of an average
inter-domain distance of 4.5nm for domains 1, 2 and 3 (Petoukhov
et al, 2006), we constrained their separation to be 1–6 nucleotides.
RRM4 was omitted because there is no clear distance constraint
(Oberstrass et al, 2005; Lamichhane et al, 2010). Thus, an optimal-
binding site was taken to be YCUN(1–6)CUN(3–8)YCU, where N is any
nucleotide. The total number of conﬁgurations is 144, which is the
product of the variable lengths of the spacers and the two
pyrimidines (Y). An array of 22 bases was deﬁned in Cþþ and
all allowed conﬁgurations were generated, which were then
compared with the RNA sequence at every position. Each
nucleotide position matching the optimal site was given a value
of 1, and the sum of these taken as a score, the maximum score
possible being 8. Alignments were ranked according to their score.
The ﬁgures show positions that scored the maximum. For
determining whether two or three PTB molecules would ﬁt on a
sequence, an initial array was scored and those showing a perfect
match held while a second array was scored and so on. In this case,
gaps of at least three bases between adjacent arrays were required.
Conﬁgurations scoring the maximum possible (24) were plotted.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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